SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043570
Filing Date
2024-05-15
Accepted
2024-05-15 16:02:08
Documents
98
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0205871-20f_nlspharma.htm   iXBRL 20-F 1727013
2 DESCRIPTION OF SECURITIES ea020587101ex2-1_nlspharma.htm EX-2.1 113199
3 AMENDMENT NO. 1 TO PRE-FUNDED WARRANT DATED APRIL 26, 2023 BETWEEN NLS PHARMACEU ea020587101ex4-17_nlspharma.htm EX-4.17 22302
4 LICENSE AGREEMENT BY AND BETWEEN NLS PHARMACEUTICS LTD. AND AEXON LABS INC., DAT ea020587101ex4-18_nlspharma.htm EX-4.18 208914
5 CERTIFICATION ea020587101ex12-1_nlspharma.htm EX-12.1 9811
6 CERTIFICATION ea020587101ex12-2_nlspharma.htm EX-12.2 9864
7 CERTIFICATION ea020587101ex13-1_nlspharma.htm EX-13.1 3436
8 CERTIFICATION ea020587101ex13-2_nlspharma.htm EX-13.2 3372
9 CONSENT OF PRICEWATERHOUSECOOPERS AG. ea020587101ex15-1_nlspharma.htm EX-15.1 2154
10 LETTER OF PRICEWATERHOUSECOOPERS AG DATED MAY 15, 2024 ea020587101ex16-1_nlspharma.htm EX-16.1 4923
11 CLAWBACK POLICY ea020587101ex97-1_nlspharma.htm EX-97.1 40514
12 GRAPHIC image_001.jpg GRAPHIC 23027
13 GRAPHIC image_002.jpg GRAPHIC 36341
14 GRAPHIC image_003.jpg GRAPHIC 36341
15 GRAPHIC image_004.jpg GRAPHIC 44891
16 GRAPHIC image_005.jpg GRAPHIC 58721
17 GRAPHIC image_006.jpg GRAPHIC 28698
18 GRAPHIC image_007.jpg GRAPHIC 34712
19 GRAPHIC image_008.jpg GRAPHIC 34468
20 GRAPHIC image_009.jpg GRAPHIC 75699
21 GRAPHIC image_010.jpg GRAPHIC 24006
22 GRAPHIC image_011.jpg GRAPHIC 82185
23 GRAPHIC image_012.jpg GRAPHIC 22549
24 GRAPHIC image_013.jpg GRAPHIC 11260
25 GRAPHIC image_014.jpg GRAPHIC 18476
26 GRAPHIC image_015.jpg GRAPHIC 13754
27 GRAPHIC image_016.jpg GRAPHIC 18610
28 GRAPHIC image_017.jpg GRAPHIC 50893
29 GRAPHIC image_018.jpg GRAPHIC 35923
30 GRAPHIC ex16-1_001.jpg GRAPHIC 5010
  Complete submission text file 0001213900-24-043570.txt   8684734

Data Files

Seq Description Document Type Size
31 XBRL SCHEMA FILE nlsp-20231231.xsd EX-101.SCH 58671
32 XBRL CALCULATION FILE nlsp-20231231_cal.xml EX-101.CAL 50061
33 XBRL DEFINITION FILE nlsp-20231231_def.xml EX-101.DEF 291882
34 XBRL LABEL FILE nlsp-20231231_lab.xml EX-101.LAB 571990
35 XBRL PRESENTATION FILE nlsp-20231231_pre.xml EX-101.PRE 307799
102 EXTRACTED XBRL INSTANCE DOCUMENT ea0205871-20f_nlspharma_htm.xml XML 536156
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39957 | Film No.: 24950180
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)